GB1200157A - Concentrated liquid antacid compositions - Google Patents

Concentrated liquid antacid compositions

Info

Publication number
GB1200157A
GB1200157A GB17074/69A GB1707469A GB1200157A GB 1200157 A GB1200157 A GB 1200157A GB 17074/69 A GB17074/69 A GB 17074/69A GB 1707469 A GB1707469 A GB 1707469A GB 1200157 A GB1200157 A GB 1200157A
Authority
GB
United Kingdom
Prior art keywords
phosphate
gluconate
calcium
april
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17074/69A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB1200157A publication Critical patent/GB1200157A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Abstract

1,200,157. Pharmaceutical vehicle; antacid composition. SMITH KLINE & FRENCH LABORATORIES. 1 April, 1969 [5 April, 1968], No. 17074/69. Heading A5B. An aqueous pharmaceutical vehicle comprises a combination of monobasic calcium phosphate and at least one of sodium, potassium, calcium or magnesium gluconate dissolved in water, wherein the phosphate and gluconate are each present in an amount from 0.5-7.0% W/V, provided that the total concentration of phosphate and gluconate is from 3-10% W/V. A liquid antacid composition comprises weight/volume of from 25-50% of solid antacid material suspended in an aqueous vehicle containing monobasic calcium phosphate and at least one of sodium, potassium calcium or magnesium gluconate. Conventional additives such as preservatives, flavours and solubilizers and anti-spasmodic agents or tranquilizers or glycine may also be present.
GB17074/69A 1968-04-05 1969-04-01 Concentrated liquid antacid compositions Expired GB1200157A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71923468A 1968-04-05 1968-04-05

Publications (1)

Publication Number Publication Date
GB1200157A true GB1200157A (en) 1970-07-29

Family

ID=24889291

Family Applications (1)

Application Number Title Priority Date Filing Date
GB17074/69A Expired GB1200157A (en) 1968-04-05 1969-04-01 Concentrated liquid antacid compositions

Country Status (10)

Country Link
US (1) US3621094A (en)
AU (1) AU443154B2 (en)
BE (1) BE731060A (en)
DE (1) DE1915798C3 (en)
FR (1) FR2005599A1 (en)
GB (1) GB1200157A (en)
IE (1) IE33016B1 (en)
IL (1) IL31858A (en)
LU (1) LU58367A1 (en)
NL (1) NL6905135A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1076479A (en) * 1976-09-17 1980-04-29 Lewis/Howe Company Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof
JPS58192739U (en) * 1982-06-19 1983-12-21 仁川　春夫 Vehicle towing repair car
DE3343793A1 (en) * 1983-12-03 1985-08-01 Franz 8400 Regensburg Schöberl Towing-away device for motor vehicles
US4548817A (en) * 1984-01-20 1985-10-22 Webb-Waring Lung Institute Composition and method for treating mammalian acidosis
JPS62502261A (en) * 1985-03-27 1987-09-03 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ↓−ポレイテッド Replenishment calcium addition unit
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
CA2168959A1 (en) * 1993-10-13 1995-04-20 Constantine Georgiades Antacid pharmaceutical composition
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
US20060257358A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
EP2182810B1 (en) * 2007-08-03 2017-11-08 Nucitec S.A. de C.V. Compositions and methods for treatment and prevention of osteoarthritis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062714A (en) * 1960-03-11 1962-11-06 Lewis Howe Company Antacid composition
US3215601A (en) * 1963-02-07 1965-11-02 Warner Lambert Pharmaceutical Antacid composition and method of making same
US3361769A (en) * 1964-01-22 1968-01-02 Synergistics Inc Bi-metallic salts of gluconic, glucuronic, or galacturonic acid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate

Also Published As

Publication number Publication date
IE33016L (en) 1969-10-05
DE1915798C3 (en) 1978-04-27
DE1915798A1 (en) 1969-11-06
NL6905135A (en) 1969-10-07
IL31858A (en) 1972-05-30
IL31858A0 (en) 1969-05-28
US3621094A (en) 1971-11-16
BE731060A (en) 1969-10-06
DE1915798B2 (en) 1977-08-25
AU443154B2 (en) 1973-11-28
LU58367A1 (en) 1970-11-09
AU5219669A (en) 1970-09-24
FR2005599B1 (en) 1973-12-21
FR2005599A1 (en) 1969-12-12
IE33016B1 (en) 1974-02-20

Similar Documents

Publication Publication Date Title
GB1200157A (en) Concentrated liquid antacid compositions
GB1139430A (en) Improvements relating to surgical cements
GB1430634A (en) Fibres of regenerated cellulose and polyacrylic acid salt of alkali-metals
GB1372008A (en) Water-in-oil emulsions
SU513645A3 (en) Reagent for the determination of glucose
GB1190657A (en) Additive Composition for use in Sugar Manufacture
DE3067351D1 (en) Dentifrice with high foaming ability
GB1313645A (en) Flavouring process employing and compositions containing 3-phenyl pentenals
DE3478029D1 (en) Biopolymer compositions and process for their preparation
IL37280A (en) Adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB1403900A (en) Pharmaceutical composition
ES344578A1 (en) Cold water-soluble eucheuma gel mixtures
GB1331190A (en) X-ray contrast composition containing barium sulphate
GB1310374A (en) Toothpaste composition
GB1270752A (en) Dentifrice compositions
GB1449146A (en) Prostaglandins and the preparation thereof
GB1354263A (en) Therapeutic composition
GB1275885A (en) Antacid compositions
ES335190A1 (en) Improvements introduced in the preparation of compositions to stop welding. (Machine-translation by Google Translate, not legally binding)
GB1201423A (en) Improvements in or relating to iron salt-antibiotic compositions
GB1273092A (en) 2-allyloxyinosine-5'-phosphate
DE707256C (en) Process for preventing the corrosion of aluminum metal by ointment or paste-like masses
GB478629A (en) Improvements relating to finely granular kitchen salt preparations
FR2469712A1 (en) ABRINE-CONTAINING IMMUNOPOTENTIALIZER AND THERAPEUTIC COMPOSITION CONTAINING THE SAME
GB1217210A (en) Mixed herbicidal compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee